Middle East Pharmaceutical Industries Company Current Assets

Middle East Pharmaceutical Industries Company (4016.SR) currently reports a current assets of $480M as of June 2026. That compares with $380M in the prior-year period — up 26.4% year over year. Use the charts on this page to explore Middle East Pharmaceutical Industries Company's current assets history and peer comparisons.

Middle East Pharmaceutical Industries Company's current assets increased from $380M to $480M — a 26.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Middle East Pharmaceutical Industries Company reported $480M in current assets as of June 2026. That compares with $380M in the prior-year period — up 26.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $480M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Middle East Pharmaceutical Industries Company, and consider following 4016.SR for alerts when major investors trade the stock.